RPG Life Sciences Limited
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in the domestic and international market.The company is a part of RPG group which is a diversified conglomerate with interests in areas of infrastructure, tyres, information technology, pharmaceuticals, energy and plantations.The group is headed by Harsh Goenka.
What RPG files
- Others64
- Updates30
- Important25
- Investor Meet25
- Board Meeting15
- PPTs10
RPG Life Sciences completed the transfer of its API Business via a slump sale to its wholly-owned subsidiary, RPG Active Pharma Limited. This operational restructuring is now effective, streamlining the Active Pharmaceuticals Ingredients unit under the new entity.
RPG Life Sciences invested Rs. 65.68 Cr in its wholly-owned subsidiary, RPG Active Pharma, through a rights issue. This investment maintains 100% ownership in RPGAP, a new pharmaceutical entity yet to commence operations, positioning it for future operational development.
RPG Life Sciences has announced a board meeting where it approved financial results for the quarter and year ended March 31, 2026. Annual revenue reached Rs 707.52 Cr with profit at Rs 117.35 Cr. A Rs 24 per share dividend was also declared, pending shareholder approval.
Company encourages shareholders to participate in the 'Saksham Niveshak' campaign. This initiative aims to help investors update KYC details, bank mandates, and nominations, facilitating claims for any unpaid/unclaimed dividends.
RPG Life Sciences formed RPG Active Pharma Limited, a new wholly-owned subsidiary. This strategic move could signal a sharper focus on active pharmaceutical ingredients or new business ventures.